Program overview
Context
Indication: Lymphoma, Non-Hodgkin
Mechanism: Unknown
Modality: Unknown
Sponsor: Celgene
Operational Burden Signal
Fludarabine
Fludarabine is flagged as operational burden signal because public records show operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 0/5
Timeline: 1/5
Recruitment burden: 3/5
Results availability: 0/5
Program risk: 2/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT04245839 | https://clinicaltrials.gov/study/NCT01991457 | https://clinicaltrials.gov/study/NCT01585428
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT04245839 | Low Signal (ACTIVE_NOT_RECRUITING) | long_recruitment_duration_signal | Low Signal | large_enrollment_target_signal | strict_eligibility_signal | complex_intervention_signal |
| NCT01991457 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | rare_population_signal |
| NCT01585428 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | rare_population_signal | strict_eligibility_signal |